AB ANALITICA Trademark

Trademark Overview


On Thursday, March 21, 2024, a trademark application was filed for AB ANALITICA with the United States Patent and Trademark Office. The USPTO has given the AB ANALITICA trademark a serial number of 79399168. The federal status of this trademark filing is NON-FINAL ACTION COUNTED - NOT MAILED as of Tuesday, October 8, 2024. This trademark is owned by AB ANALITICA S.r.l.. The AB ANALITICA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical drugs; pharmaceutical compositions; pharmaceuticals; pharmaceutical preparations; chemico-pharmaceutical preparations; gastrointestinal preparations; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; milk sugar; milk sugar for pharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations and materials; clinical medical reagents; clinical diagnostic reagents; diagnostic agents for medical use; diagnostic substances for medical use; diagnostic agents for pharmaceutical use; indicators for medical diagnosis; pregnancy testing preparations; in vitro diagnostic preparations for medical use; reagents for in-vitro laboratory use (for veterinary purposes); reagents for in-vitro laboratory use (for medical purposes); pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the ...

Pharmaceutical drug development services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical and pharmacological research services; medical research laboratory services; testing of pharmaceuticals; research on the subject of pharmaceuticals; research and development of vaccines and medicines; design and development of medical diagnostic apparatus; scientific research for medical purposes in the area of cancerous diseases; research and development in the field of diagnostic preparations; genetic research; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; laboratory research in the field of gene expression; DNA screening for scientific research purposes; DNA testing services to determine paternity (laboratory services); analysis of product development; analysis and evaluation of product development; analysis of product design; analysis and evaluation of product design; quality con...
ab analitica

General Information


Serial Number79399168
Word MarkAB ANALITICA
Filing DateThursday, March 21, 2024
Status640 - NON-FINAL ACTION COUNTED - NOT MAILED
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical drugs; pharmaceutical compositions; pharmaceuticals; pharmaceutical preparations; chemico-pharmaceutical preparations; gastrointestinal preparations; medicines for the treatment of gastrointestinal diseases; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; milk sugar; milk sugar for pharmaceutical purposes; vaccines; diagnostic preparations for medical purposes; diagnostic preparations and materials; clinical medical reagents; clinical diagnostic reagents; diagnostic agents for medical use; diagnostic substances for medical use; diagnostic agents for pharmaceutical use; indicators for medical diagnosis; pregnancy testing preparations; in vitro diagnostic preparations for medical use; reagents for in-vitro laboratory use (for veterinary purposes); reagents for in-vitro laboratory use (for medical purposes); pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; compounds for treating cancer; male fertility test kits; reagents for medical use; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; reagents for use with analyzers (for medical purposes); diagnostic chemical reagents for medical use; reagents for use in analysis (for medical purposes); chemical test reagents (medical); diagnostic biomarker reagents for medical purposes; reagents for use in diagnostic tests (for medical purposes); reagents for microbiological analysis (for medical purposes); chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in diagnostic tests (for veterinary purposes); reagents for analytical purposes (for medical purposes); medical diagnostic reagents and assays for testing of body fluids; reagents for use in diagnostic pregnancy tests; reagents for use in analysis (for veterinary purposes); culture media for medical use; medical preparations; reagents for use in veterinary genetic testing; biochemical preparations for medical use; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; preparations for detecting mutation in prion genes for medical purposes; preparations for detecting genetic predispositions for medical purposes; glucose for medical purposes; glucose dietary supplements; glucose for use as an additive to foods for medical purposes; pharmaceutical preparations for the prevention of disorders of the metabolic system; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations for treating gastrointestinal disorders; DNA synthesis inhibitors; chemical preparations for use in DNA analysis (medical); medical diagnostic test strips; dietary supplements and dietetic preparations; pharmaceuticals and natural remedies; diagnostic preparations for medical or veterinary purposes.
Goods and ServicesPharmaceutical drug development services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical and pharmacological research services; medical research laboratory services; testing of pharmaceuticals; research on the subject of pharmaceuticals; research and development of vaccines and medicines; design and development of medical diagnostic apparatus; scientific research for medical purposes in the area of cancerous diseases; research and development in the field of diagnostic preparations; genetic research; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; laboratory research in the field of gene expression; DNA screening for scientific research purposes; DNA testing services to determine paternity (laboratory services); analysis of product development; analysis and evaluation of product development; analysis of product design; analysis and evaluation of product design; quality control; design and testing for new product development; design and testing of new products; scientific research and development; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; research and development services; pharmaceutical research and development; research and development of computer software; development of testing methods; quality control of manufactured goods; design and development of computer hardware; software design and development; design of instruments; design services relating to data processing tools; design and development of diagnostic apparatus; product research and development; computer design research; development of pharmaceutical preparations and medicines; scientific investigations for medical purposes; biological research, clinical research and medical research; research in the field of pharmacogenetics; laboratory testing; laboratory services; research and development in the field of microorganisms and cells; research relating to molecular sciences; research and development in the field of biotechnology; bacteriological research; testing, authentication and quality control; biological research and analysis; physics [research]; chemical research; scientific research relating to biology; biological research laboratory services; research and development services in the field of immunohistology; provision of research services; leasing of scientific instruments; computer rental; software development, programming and implementation; data mining; computer software design and updating; preparation of technical reports; preparation of scientific reports; technological research; analysis in the field of molecular biology; biological research.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 8, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAB ANALITICA S.r.l.
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressIT

Trademark Events


Event DateEvent Description
Thursday, July 4, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 8, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, July 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, October 8, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 9, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, September 28, 2024ASSIGNED TO EXAMINER